Lim Jonathan E has filed 27 insider transactions across 3 companies since November 2022.
Most recent transaction: a grant/award of 2000000 shares of Erasca, Inc. ($ERAS) on January 29, 2026.
Activity breakdown: 6 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 29, 2026 | Erasca, Inc. | $ERAS | Lim Jonathan E | Chairman & CEO | A | Stock option (right to buy) | 2000000 | $0.00 | 2,000,000.0000 | 283,711,805 | 9999.99% | 0.70% |
| Sept. 22, 2025 | Maze Therapeutics, Inc. | $MAZE | Lim Jonathan E | Not found | A | Stock Option (Right to Buy) | 18000 | $0.00 | 18,000.0000 | 0 | 9999.99% | 0.00% |
| June 23, 2025 | Boundless Bio, Inc. | $BOLD | Lim Jonathan E | Not found | A | Stock Option (right to buy) | 24000 | $0.00 | 24,000.0000 | 22,300,000 | 9999.99% | 0.11% |
| Feb. 3, 2025 | Erasca, Inc. | $ERAS | Lim Jonathan E | Chairman & CEO | A | Stock option (right to buy) | 2500000 | $0.00 | 2,500,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 9, 2024 | Maze Therapeutics, Inc. | $MAZE | Lim Jonathan E | Not found | A | Stock Option (Right to Buy) | 9086 | $0.00 | 9,086.0000 | 0 | 9999.99% | 0.00% |
| Dec. 9, 2024 | Maze Therapeutics, Inc. | $MAZE | Lim Jonathan E | Not found | D | Stock Option (Right to Buy) | 5704 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 9, 2024 | Maze Therapeutics, Inc. | $MAZE | Lim Jonathan E | Not found | A | Stock Option (Right to Buy) | 5704 | $0.00 | 5,704.0000 | 0 | 9999.99% | 0.00% |
| Feb. 3, 2025 | Maze Therapeutics, Inc. | $MAZE | Lim Jonathan E | Not found | C | Common Stock | 270232 | $0.00 | 328,700.0000 | 0 | 462.19% | 0.00% |
| Feb. 3, 2025 | Maze Therapeutics, Inc. | $MAZE | Lim Jonathan E | Not found | C | Series A Preferred Stock | 363703 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 3, 2025 | Maze Therapeutics, Inc. | $MAZE | Lim Jonathan E | Not found | C | Series B Preferred Stock | 2231381 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 3, 2025 | Maze Therapeutics, Inc. | $MAZE | Lim Jonathan E | Not found | C | Common Stock | 37724 | $0.00 | 58,468.0000 | 0 | 181.86% | 0.00% |
| June 20, 2024 | Erasca, Inc. | $ERAS | Lim Jonathan E | Chairman & CEO | A | Stock Option (right to buy) | 632759 | $0.00 | 632,759.0000 | 0 | 9999.99% | 0.00% |
| June 20, 2024 | Boundless Bio, Inc. | $BOLD | Lim Jonathan E | Not found | A | Stock Option (Right to Buy) | 6610 | $0.00 | 6,610.0000 | 1,248 | 9999.99% | 100.00% |
| April 2, 2024 | Boundless Bio, Inc. | $BOLD | Lim Jonathan E | Not found | C | Series A Convertible Preferred Stock | 512820 | $0.00 | 0.0000 | 1,248 | 100.00% | 100.00% |
| April 2, 2024 | Boundless Bio, Inc. | $BOLD | Lim Jonathan E | Not found | C | Series C Convertible Preferred Stock | 7326 | $0.00 | 0.0000 | 1,248 | 100.00% | 100.00% |
| April 2, 2024 | Boundless Bio, Inc. | $BOLD | Lim Jonathan E | Not found | C | Series B Convertible Preferred Stock | 5128 | $0.00 | 0.0000 | 1,248 | 100.00% | 100.00% |
| April 2, 2024 | Boundless Bio, Inc. | $BOLD | Lim Jonathan E | Not found | C | Common Stock | 525274 | $0.00 | 653,479.0000 | 1,248 | 409.71% | 100.00% |
| March 27, 2024 | Boundless Bio, Inc. | $BOLD | Lim Jonathan E | Not found | A | Stock Option | 13219 | $0.00 | 13,219.0000 | 1,248 | 9999.99% | 100.00% |
| Feb. 5, 2024 | Erasca, Inc. | $ERAS | Lim Jonathan E | Chairman & CEO | A | Stock Option (right to buy) | 1500000 | $0.00 | 1,500,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 6, 2023 | Erasca, Inc. | $ERAS | Lim Jonathan E | Chairman & CEO | P | Common Stock | 278150 | $1.72 | 32,355,576.0000 | 0 | 0.87% | 0.00% |
| Dec. 5, 2023 | Erasca, Inc. | $ERAS | Lim Jonathan E | Chairman & CEO | P | Common Stock | 721850 | $1.69 | 32,355,576.0000 | 0 | 2.28% | 0.00% |
| Oct. 5, 2023 | Erasca, Inc. | $ERAS | Lim Jonathan E | Chairman & CEO | P | Common Stock | 1000000 | $2.03 | 31,355,576.0000 | 0 | 3.29% | 0.00% |
| June 8, 2023 | Erasca, Inc. | $ERAS | Lim Jonathan E | Chairman & CEO | P | Common Stock | 100000 | $2.75 | 30,295,576.0000 | 0 | 0.33% | 0.00% |
| March 28, 2023 | Erasca, Inc. | $ERAS | Lim Jonathan E | Chairman & CEO | P | Common Stock | 100000 | $2.84 | 30,195,576.0000 | 0 | 0.33% | 0.00% |
| Nov. 30, 2022 | Erasca, Inc. | $ERAS | Lim Jonathan E | Chairman and CEO | G | Common Stock | 2000006 | $0.00 | 30,095,576.0000 | 0 | 6.23% | 0.00% |
| Feb. 1, 2023 | Erasca, Inc. | $ERAS | Lim Jonathan E | Chairman & CEO | A | Stock Option (right to buy) | 1500000 | $0.00 | 1,500,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 10, 2023 | Erasca, Inc. | $ERAS | Lim Jonathan E | Chairman & CEO | P | Common Stock | 60000 | $3.86 | 32,155,582.0000 | 0 | 0.19% | 0.00% |